Eric Drape - 05 Mar 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: Executive VP Global Operations
Signature: /s/ Dov Bergwerk as attorney-in-fact for Eric Drape
Issuer symbol: TEVA
Transactions as of: 05 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 07 Mar 2024, 16:24:19 UTC
Previous filing: 05 Mar 2024
SEC: View on sec.gov

Key filing fact

Eric Drape filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 07 Mar 2024.

Key facts

This page summarizes Eric Drape's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
4 reported transactions and 2 derivative rows are listed below.
Filing timestamp: 07 Mar 2024, 16:24.

Change

Previous filing in this sequence was filed on 05 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +22,576
Change %: +33%
Price
Shares after: 90,689
Date: 05 Mar 2024
Ownership: Direct
Footnotes: F1, F2, F3

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +55,226
Change %: +61%
Price
Shares after: 145,915
Date: 05 Mar 2024
Ownership: Direct
Footnotes: F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

TEVA transaction Derivative

Restricted Share Units

Options Exercise

Transaction value: $0
Shares: -22,576
Change %: -50%
Price: $0.000000
Shares after: 22,576
Date: 05 Mar 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 22,576
Exercise price
Footnotes: F2, F4

TEVA transaction Derivative

Restricted Share Units

Options Exercise

Transaction value: $0
Shares: -55,226
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 05 Mar 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 55,226
Exercise price
Footnotes: F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3	Amount reflects the sale of 9,815 Ordinary Shares by the Reporting Person, as reported in a Form 4 filed on March 1, 2024, which was inadvertently omitted from the amount of securities beneficially owned by the Reporting Person following the transactions reported in a Form 4 filed on March 5, 2024.
F4	Restricted share units were granted on March 5, 2021, with 22,576 vested on March 5, 2022, March 5, 2023, March 5, 2024 and 22,576 vesting on March 5, 2025.
F5	Restricted share units were granted on January 30, 2024 pursuant to the satisfaction of performance criteria and vested on March 5, 2024.